Reduced-dose influenza vaccine

Annals of Pharmacotherapy

Volumn 40, Issue 9, 2006, Pages 1635-1639

  Wyatt, Katleen N ^a   Ryan, Gina J ^a   Sheerin, Kathleen A ^b  

^a MERCER UNIVERSITY   (United States)

^b Atlanta Allergy and Asthma Clinic   (United States)

Author keywords

Inactivated; Influenza vaccine; Reduced dose; Trivalent

Indexed keywords

HEMAGGLUTININ; INACTIVATED VACCINE; INFLUENZA VACCINE; TRIPLE VACCINE; VIRUS ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; DEVICE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INJECTION; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; NEEDLE; NORMAL HUMAN; PRIORITY JOURNAL; SEROCONVERSION; TREATMENT OUTCOME; VACCINATION; VIRUS INFECTION;

HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; VACCINES, INACTIVATED;

EID: 33748316609     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G645     Document Type: Article

References (13)

1. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morbid Mortal Wkly Rep 2005;54:1-22.
2. Cate TR, Couch RB, Parker D, Baxter B. Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines-1978. Rev Infect Dis 1983;5:737-47.
3. Quinnan GV, Schooley R, Dolin R, Ennis FA, Gross P, Gwaltney JM Jr. Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines. Rev Infect Dis 1983;5:748-57.
4. Wright PF, Cherry JD, Foy HM, et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children-a multicentered evaluation of dosage and toxicity. Rev Infect Dis 1983;5:758-64.
5. LaMontagne JR, Noble GR, Quinnan GV, et al. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis 1983;5:723-36.
6. Treanor J, Keitel W, Belshe R, et al. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults. Vaccine 2002; 20:1099-105. DOI 10.1016/S0264-410X(01)00440-6
7. Kenney RT, Frech SA, Muenz LF, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 2004;351: 2295-301. DOI 10.1056/NEJMoa043540
8. Belshe RB, Newman FK, Cannon J, et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 2004;351:2286-94. DOI 10.1056/NEJMoa043555
9. Jackson LA, Austin G, Chen RT, et al. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors. Vaccine 2001;19:4703-9. DOI 10.1016/S0264-410X(01) 00225-0
10. Beyer WEP, Palache AM, Luchters G, et al. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 2004;103:125-31.
11. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 1988; 127:353-64.
12. Glenn GM, Kenney RT, Hammond SA, Ellingsworth LR. Transcutaneous immunization and immunostimulant strategies. Immunol Allergy Clin North Am 2003;23:787-813.
13. Workman B. Safe injection techniques. Nurs Stand 1999;13:47-53.